Final answer:
Strontium ranelate is a medication used to treat osteoporosis that can increase bone density and reduce the risk of fractures. However, treatments like bisphosphonates, calcitonin, and estrogen are more commonly prescribed, and potential risks must be weighed. Lifestyle changes are also important in managing the disease.
Step-by-step explanation:
Can Strontium Ranelate Help in Treating Low Bone Density?
Treating low bone density and preventing osteoporotic fractures is crucial in managing osteoporosis, particularly among women who are at a higher risk of spinal fractures. The gold standard treatments currently include medications such as bisphosphonates, calcitonin, and estrogen replacement therapy (for women). These treatments are geared towards slowing down the breakdown of bone tissue, promoting bone rebuilding during remodeling, and maintaining bone density.
However, patients are usually not recommended to stay on bisphosphonates for more than three or four years due to the lack of evidence of continued benefit beyond this time and the potential for adverse side effects. Additionally, lifestyle adjustments like undertaking weight-bearing exercise, ensuring adequate nutritional intake of calcium and vitamin D, and minimizing fall risks by creating a safer living environment are also part of comprehensive management strategies.
While strontium ranelate is not mentioned in the provided reference materials, it is another medication that has been used to treat osteoporosis by increasing bone formation and reducing bone resorption, which could result in increased bone density and reduced risk of fractures. However, the use of strontium ranelate must be considered carefully against its potential risks and side effects.